Preclinical evaluation of WVE-004, aninvestigational stereopure oligonucleotide forthe treatment of C9orf72-associated ALS or FTD

by Andreucci, A., Bulychev, A., Dale, E., Hu, X.S, Iwamoto, N., Lamore, S., Lin, X., Liu, F., Liu, Y., Mohapatra, S., Patil, S., Purcell-Estabrook, E., Taborn, K., Vargeese, C., Yang, H., Yin, Y.
Published 2022